首页> 外国专利> MTOR cinasa inhibitors for tumor and disease markers related to mTOR / PI3K / Akt trajectories

MTOR cinasa inhibitors for tumor and disease markers related to mTOR / PI3K / Akt trajectories

机译:MTOR cinasa抑制剂,用于与mTOR / PI3K / Akt轨迹相关的肿瘤和疾病标记

摘要

It refers to the compound in 3,4-dihydropyridine [2,3-b] Pyridine-2 (1H) - formula (II), wherein R1 is isomerized or isomerized, such as pyridine, pyridine, pyridine, 1H pyridine [2,3-b] pyridine, etc.; R2 is h, hydrocarbon (C1-C8),Cyclopropyl (C3-C10),Among other things, isocyclohexane; R3 is h or tar (C1-C8). - [1 - [1 - [2]] - 1,4 - [1,4] - 1 - [(8-isopropyl-7-oxo-5,6,7,8-tetrahydropyridine [2,3-b] pyridine-2-il) - 4-methylpyridine; Someone else He also mentioned a pharmaceutical composer These compounds are enzyme inhibitors and are useful in the treatment of cancer, flammable screws, and immunology.
机译:它是指3,4-二氢吡啶[2,3-b]吡啶-2(1H)-式(II)中的化合物,其中R1是异构体或异构体,例如吡啶,吡啶,吡啶,1H吡啶[2, 3-b]吡啶等; R 2是h,烃(C 1 -C 8),环丙基(C 3 -C 10),其中,异环己烷; R3是h或tar(C1-C8)。 -[1-[1-[2]]-1,4-[1,4]-1-[[(8-异丙基-7-氧代-5,6,7,8-四氢吡啶[2,3-b]吡啶-2-il)-4-甲基吡啶;他还提到了其他药物的合成人。这些化合物是酶抑制剂,可用于治疗癌症,易燃螺丝钉和免疫学。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号